  See all
 |
Articles: Pharmacology/Therapy |
Prior Articles
Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma
Journal of Neuro-Oncology, 10/26/09
Predicting for activity of second-line trastuzumab-based therapy in Her2-positive advanced breast cancer
BMC Cancer, 10/23/09
Free full text
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09 Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09 The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer
European Journal of Cancer, 10/23/09 Phase I trial of vinflunine and pemetrexed in refractory solid tumors
Investigational New Drugs, 10/23/09 Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09 Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma
Investigational New Drugs, 10/23/09 Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09 Favorable coagulation profile with fondaparinux after hip surgery in elderly patients
International Journal of Hematology, 10/23/09 Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
Cancer Science, 10/23/09 Review of (90)Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin’s lymphoma
Cancer Management and Research, 10/23/09 Romiplostim in chronic immune thrombocytopenic purpura
Clinical Therapeutics, 10/23/09
Revew Article
Update on Thalassemia Treatment in Taiwan, Including Bone Marrow Transplantation, Chelation Therapy, and Cardiomyopathy Treatment Effects
Hemoglobin, 10/23/09 A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and other Chronically Transfused Patients
Hemoglobin, 10/23/09 Advances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications
Hemoglobin, 10/23/09 A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
Investigational New Drugs, 10/23/09 Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
Oral Oncology, 10/23/09 Significance of thymidylate synthase for resistance to pemetrexed in lung cancer
Cancer Science, 10/23/09 Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10
Journal of Clinical Oncology, 10/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
